Regulatory Spine FDA Accepts & Closes Empirical Spine’s LimiFlex™ PMA Module II As A Motion-Preserving Alternative To Lumbar Fusion byChris StewartJuly 13, 2022
Regulatory Spine Centinel Spine® Receives FDA Approval for 3 Additional prodisc® Cervical Total Disc Replacement Devices byJosh SandbergJuly 13, 2022
Extremities Regulatory Spine Top Stories FDA Grants PMA for the AccelStim Bone Growth Stimulation Device — Expanding Orthofix’s Portfolio of Market-Leading Bone Healing Therapy Solutions byChris StewartMay 4, 2022
Extremities Regulatory Top Stories FDA approves CartiHeal’s Implant for the Treatment of Cartilage and Osteochondral Defects byJosh SandbergMarch 30, 2022
Regulatory Spine AxioMed LLC Files PMA Module II of III targeting 2022 FDA Approval of The First and Only Viscoelastic Lumbar Disc Replacement to Complete an IDE Clinical Study byJosh SandbergFebruary 3, 2022
Regulatory Spine Top Stories AxioMed LLC Reports Landmark Filing of Initial PMA Module to FDA as the First Viscoelastic Lumbar Artificial Disc Replacement to Complete an IDE Clinical Study byJosh SandbergDecember 3, 2021
Spine Simplify Medical Completes PMA Submission for 2-Level Simplify Disc IDE Study byJosh SandbergOctober 29, 2020
Biologics Regulatory Spine Cerapedics Announces FDA Approval of PMA Supplement Based on Two-Year Clinical Data byJosh SandbergNovember 18, 2019
Hospitals MCRA Assists Cartiva, Inc. with Obtaining FDA PMA Approval for the Company’s Synthetic Cartilage Implant (SCI) byJosh SandbergJuly 21, 2016
Extremities FDA Questions First PMA for Synthetic Cartilage Implant Ahead of Advisory Panel byJosh SandbergApril 21, 2016